Second Quarter 2012 Review: Diagnostic Company Financial Summaries

source Regroup and Look for Q4 Drivers

A lackluster earnings quarter that evokes the blahs. The hottest Company in the sector Cepheid (CPHD $36.12), took an earnings hit, driving the stock down 30% to the $32 level now recovering. This life science sector has not participated in the recent NASDAQ rally and biopharmaceutical stocks (now looking toppy) have outperformed. We are cautious so keep a lot of cash for rebalancing. Two stocks that have taken big hits that warrant review are Alere (ALR $18.74) and Luminex(LMNX $18.35).

Our focus stocks in Diagnostics and Tools hit their highs in mid-July. We added ThermoFisher http://laurier-optical.com/locations/?wpsl-search-input=P0M (TMO) at $53.5 and reiterated Illumina go to link (ILMN $41.51) buy under $40.

Company Ticker Price RevEst Q2Rev Price 2011 P/S PE PEG SE
May’11 2012 yr 2012 15-Aug Rev BV
GenProbe** GPRO 80 642 153 82.75 576 5.8 64 1.9 700
Abaxis ABAX 28 181 42 38.76 155 4.7 63 2.9 164
Alere ALR 36 2,780 701.6 18.73 2386 0.6 n/a 0.7 2,191
Cepheid CPHD 30.5 334 81 36.63 70.2 7.2 n/a 92 240
ChemBio CEMI n/a 25.3 6 4.95 19.4 1.6 6 1.3 13.5
ExactSci EXAS 7 4.12 1 10.6 4 152 n/a n/a 64
GenomHlth GHDX 25.85 236 57.6 30.16 206 4.6 135 5.7 134
Immucor* BLUD 20.3 345 83.3 27 n/a 5.5 21.2 2.2 n/a
Luminex LMNX 20 208 48.3 18.22 184 3.6 65 1.3 255
Meridian VIVO 23.4 173 42 18.18 160 4.3 23.9 1.6 141
Neogen NEOG 40.6 206 48.5 40 173 4.6 43 1.9 219
Orasure OSUR 7 90.4 22.6 10.5 82 6.6 n/a n/a 99
Qiagen QGEN 20 1,230 307 17.5 1170 3.3 42.7 2 2,548
Quidel QDEL 14.55 149 30.8 16.55 158 3.7 n/a 3.3 185
RespGene RGDX 2 16.5 3.84 0.8 22.6 4.9 n/a n/a -6.1
Sequenom SQNM 7 86 18.2 3.6 55.9 4.8 n/a n/a 102
SeraCare# SRLS 3.7 46.2 11 4 43.5 1.8 36.3 n/a 40.3
Techne TECH 80.5 322 83.6 67 290 7.6 22 1.8 644
* sold for $1.97B to TBG Capital #sold for $80M **sold for $3.75B
No comments yet.

Leave a Reply